Pages that link to "Q40593412"

The following pages link to In vitro and in vivo characterization of doxorubicin and vincristine coencapsulated within liposomes through use of transition metal ion complexation and pH gradient loading (Q40593412):

Displaying 30 items.

• Targeting cancer cells in the tumor microenvironment: opportunities and challenges in combinatorial nanomedicine. (Q30279055) (← links)
• Impact of metronomic UFT/cyclophosphamide chemotherapy and antiangiogenic drug assessed in a new preclinical model of locally advanced orthotopic hepatocellular carcinoma (Q33728605) (← links)
• RGD-modified apoferritin nanoparticles for efficient drug delivery to tumors (Q34652361) (← links)
• Liposomal nanomedicines (Q37039021) (← links)
• The use of single chain Fv as targeting agents for immunoliposomes: an update on immunoliposomal drugs for cancer treatment (Q37717652) (← links)
• Use of nanoscale delivery systems to maintain synergistic drug ratiosin vivo (Q37813687) (← links)
• Drug delivery systems for differential release in combination therapy (Q37827881) (← links)
• Active methods of drug loading into liposomes: recent strategies for stable drug entrapment and increasedin vivoactivity (Q37865021) (← links)
• Nanoscale delivery systems for multiple drug combinations in cancer. (Q37951607) (← links)
• Gemcitabine-loaded innovative nanocarriers vs GEMZAR: biodistribution, pharmacokinetic features and in vivo antitumor activity. (Q37955222) (← links)
• The holistic 3M modality of drug delivery nanosystems for cancer therapy (Q38071901) (← links)
• Nanoscale particulate systems for multidrug delivery: towards improved combination chemotherapy (Q38183852) (← links)
• Nanoencapsulation for drug delivery (Q38594967) (← links)
• Sensitization of multidrug-resistant malignant cells by liposomes co-encapsulating doxorubicin and chloroquine through autophagic inhibition (Q38767149) (← links)
• Organic nanoparticle systems for spatiotemporal control of multimodal chemotherapy (Q38836010) (← links)
• Co-delivery of doxorubicin and PEGylated C16-ceramide by nanoliposomes for enhanced therapy against multidrug resistance (Q38862896) (← links)
• Liposomes loaded with a dirhenium compound and cisplatin: preparation, properties and improved in vivo anticancer activity. (Q38958186) (← links)
• Gadolinium-based cancer therapeutic liposomes for chemotherapeutics and diagnostics (Q39605175) (← links)
• Biocompatibility of bacterial magnetosomes: Acute toxicity, immunotoxicity and cytotoxicity (Q39663121) (← links)
• Nigericin-mediated liposome loading of topotecan: Is nigericin a potential drug release regulator? (Q39672628) (← links)
• Therapeutic potential of new 4-hydroxy-tamoxifen-loaded pH-gradient liposomes in a multiple myeloma experimental model (Q39759380) (← links)
• Tumor-specific liposomal drug release mediated by liposomase. (Q39774851) (← links)
• Artificial Lipid Membranes: Past, Present, and Future. (Q41666646) (← links)
• Anti-tumor activity of liposome encapsulated fluoroorotic acid as a single agent and in combination with liposome irinotecan (Q41967128) (← links)
• HPMA-based polymer therapeutics improve the efficacy of surgery, of radiotherapy and of chemotherapy combinations (Q42782242) (← links)
• Pharmacokinetics of liposomal-encapsulated and un-encapsulated vincristine after injection of liposomal vincristine sulfate in beagle dogs (Q44305714) (← links)
• Simultaneous observation of the metabolism of cisplatin and NAMI-A in human plasma in vitro by SEC-ICP-AES. (Q51756809) (← links)
• Multiseed liposomal drug delivery system using micelle gradient as driving force to improve amphiphilic drug retention and its anti-tumor efficacy. (Q52679994) (← links)
• Therapeutic PEG-ceramide nanomicelles synergize with salinomycin to target both liver cancer cells and cancer stem cells. (Q52876806) (← links)
• Camouflaging Nanoparticles for Ratiometric Delivery of Therapeutic Combinations (Q64264885) (← links)